loadpatents
name:-0.043024063110352
name:-0.035753965377808
name:-0.0091118812561035
McGuigan; Christopher Patent Filings

McGuigan; Christopher

Patent Applications and Registrations

Patent applications and USPTO patent grants for McGuigan; Christopher.The latest application filed is for "2' and/or 5' amino-acid ester phosphoramidate 3'-deoxy adenosine derivatives as anti-cancer compounds".

Company Profile
9.40.40
  • McGuigan; Christopher - Cardiff GB
  • McGuigan; Christopher - Cardiff South Glamorgan GB
  • McGuigan; Christopher - Peterson Super Ely GB
  • McGuigan; Christopher - Whitchurch GB
  • McGuigan; Christopher - Whitechurch GB
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
2' And/or 5' Amino-acid Ester Phosphoramidate 3'-deoxy Adenosine Derivatives As Anti-cancer Compounds
App 20220306675 - Griffith; Hugh ;   et al.
2022-09-29
2' and/or 5' amino-acid ester phosphoramidate 3'-deoxy adenosine derivatives as anti-cancer compounds
Grant 11,352,387 - Griffith , et al. June 7, 2
2022-06-07
Phosphoramidate Derivatives Of 5 - Fluoro - 2` - Deoxyuridine For Use In The Treatment Of Cancer
App 20220023330 - McGuigan; Christopher ;   et al.
2022-01-27
Phosphorodiamidates and other phosphorus derivatives of fingolimod and related S1P receptor modulators
Grant 11,078,221 - Lloyd-Evans , et al. August 3, 2
2021-08-03
Process for preparing nucleoside prodrugs
Grant 11,040,997 - McGuigan , et al. June 22, 2
2021-06-22
Phosphoramidate Nucleoside Derivatives As Anticancer Agents
App 20210130387 - Griffith; Hugh ;   et al.
2021-05-06
Phosphoramidate derivatives of 5-fluoro-2'-deoxyuridine for use in the treatment of cancer
Grant 10,993,957 - McGuigan , et al. May 4, 2
2021-05-04
Cancer Treatments Based On Gemcitabine Prodrugs
App 20210100825 - Griffith; Hugh ;   et al.
2021-04-08
Phosphoramidate nucleoside derivatives as anticancer agents
Grant 10,906,929 - Griffith , et al. February 2, 2
2021-02-02
Gemcitabine Prodrugs
App 20200262861 - Griffith; Hugh ;   et al.
2020-08-20
Phosphorodiamidates And Other Phosphorus Derivatives Of Fingolimod And Related S1 P Receptor Modulators
App 20200255460 - Kind Code
2020-08-13
2' And/or 5' Amino-acid Ester Phosphoramidate 3'-deoxy Adenosine Derivatives As Anti-cancer Compounds
App 20200181189 - Griffith; Hugh ;   et al.
2020-06-11
Gemcitabine prodrugs
Grant 10,662,213 - Griffith , et al.
2020-05-26
2' and/or 5' amino-acid ester phosphoramidate 3'-deoxy adenosine derivatives as anti- cancer compounds
Grant 10,570,168 - Griffith , et al. Feb
2020-02-25
Adenosine Derivatives For Use In The Treatment Of Cancer
App 20190375778 - Griffith; Hugh ;   et al.
2019-12-12
Phosphoramidate compounds and methods of use
Grant RE47,589 - McGuigan Sep
2019-09-03
Phosphoramidate Derivatives Of 5 - Fluoro - 2` - Deoxyuridine For Use In The Treatment Of Cancer
App 20190201432 - McGuigan; Christopher ;   et al.
2019-07-04
Cancer Treatments Based On Gemcitabine Prodrugs
App 20180289733 - Griffith; Hugh ;   et al.
2018-10-11
Process For Preparing Nucleoside Prodrugs
App 20180273575 - McGuigan; Christopher ;   et al.
2018-09-27
Phosphoramidate derivatives of 5-fluoro-2'-deoxyuridine for use in the treatment of cancer
Grant 10,022,390 - McGuigan , et al. July 17, 2
2018-07-17
Phosphoramidate Derivatives Of 5 - Fluoro - 2` - Deoxyuridine For Use In The Treatment Of Cancer
App 20170312302 - McGuigan; Christopher ;   et al.
2017-11-02
2' And/or 5' Amino-acid Ester Phosphoramidate 3'-deoxy Adenosine Derivatives As Anti-cancer Compounds
App 20170253629 - Griffith; Hugh ;   et al.
2017-09-07
Phosphoramidate derivatives of 5-fluoro-2'-deoxyuridine for use in the treatment of cancer
Grant 9,655,915 - McGuigan , et al. May 23, 2
2017-05-23
Gemcitabine Prodrugs
App 20170107246 - Griffith; Hugh ;   et al.
2017-04-20
Anti-viral Pyrimidine Nucleoside Analogues
App 20160244476 - McGuigan; Christopher ;   et al.
2016-08-25
Phosphoramidate Derivatives Of 5 - Fluoro - 2` - Deoxyuridine For Use In The Treatment Of Cancer
App 20160166596 - McGuigan; Christopher ;   et al.
2016-06-16
Anti-viral pyrimidine nucleoside analogues
Grant 9,351,970 - McGuigan , et al. May 31, 2
2016-05-31
Phosphoramidite derivatives of gemcitabine for use in the treatment of cancer
Grant 9,321,798 - McGuigan April 26, 2
2016-04-26
Phosphoramidate derivatives of 5-fluoro-2'-deoxyuridine for use in the treatment of cancer
Grant 9,221,866 - McGuigan , et al. December 29, 2
2015-12-29
Process for Preparing Nucleoside Prodrugs
App 20150291650 - McGuigan; Christopher ;   et al.
2015-10-15
Phosphoramidate Derivatives Of 5-fluoro-2'-deoxyuridine For Use In The Treatment Of Cancer
App 20150183817 - McGuigan; Christopher ;   et al.
2015-07-02
Anti-viral Pyrimidine Nucleoside Derivatives
App 20150072948 - McGuigan; Christopher ;   et al.
2015-03-12
Compounds and methods for the treatment of viral infection
Grant 8,946,243 - Margolis , et al. February 3, 2
2015-02-03
Phosphoramidate derivatives of 5-fluoro-2'-deoxyuridine for use in the treatment of cancer
Grant 8,933,053 - McGuigan , et al. January 13, 2
2015-01-13
Anti-viral pyrimidine nucleoside derivatives
Grant 8,859,512 - McGuigan , et al. October 14, 2
2014-10-14
Phosphoramidate derivatives of guanosine nucleoside compounds for treatment of viral infections
Grant 8,759,318 - Chamberlain , et al. June 24, 2
2014-06-24
Phosphoramidate Derivatives Of 5 - Fluoro - 2` - Deoxyuridine For Use In The Treatment Of Cancer
App 20140057866 - McGuigan; Christopher ;   et al.
2014-02-27
Nucleoside aryl phosphoramidates and their use as anti-viral agents for the treatment of hepatitis C virus
Grant 8,658,616 - McGuigan , et al. February 25, 2
2014-02-25
Anti-Viral Pyrimidine Nucleoside Analogues
App 20140011764 - McGuigan; Christopher ;   et al.
2014-01-09
Anti-viral pyrimidine nucleoside analogues
Grant 8,551,965 - McGuigan , et al. October 8, 2
2013-10-08
Chemical compounds
Grant 8,551,966 - McGuigan , et al. October 8, 2
2013-10-08
Phosphoramidite Derivatives Of Gemcitabine For Use In The Treatment Cancer
App 20130252918 - McGuigan; Christopher
2013-09-26
Anti-Viral Pyrimidine Nucleoside Derivatives
App 20130096079 - McGuigan; Christopher ;   et al.
2013-04-18
Chemical Compounds
App 20130012468 - McGuigan; Christopher ;   et al.
2013-01-10
Anti-viral pyrimidine nucleoside derivatives
Grant 8,329,664 - McGuigan , et al. December 11, 2
2012-12-11
Phosphoramidate derivatives of nucleoside compounds for use in the treatment of cancer
Grant 8,263,575 - McGuigan , et al. September 11, 2
2012-09-11
Phosphoramidate derivatives
Grant 8,119,779 - McGuigan , et al. February 21, 2
2012-02-21
Compounds And Methods For The Treatment Of Viral Infection
App 20110184003 - Margolis; Leonid ;   et al.
2011-07-28
Phosphoramidate compounds and methods of use
Grant 7,951,787 - McGuigan May 31, 2
2011-05-31
Nucleoside Aryl Phosphoramidates And Their Use As Anti-viral Agents For The Treatment Of Hepatitus C Virus
App 20110124592 - McGuigan; Christopher ;   et al.
2011-05-26
Anti-viral Pyrimidine Nucleoside Analogues
App 20110015147 - MCGUIGAN; Christopher ;   et al.
2011-01-20
Anti-viral pyrimidine nucleoside analogues
Grant 7,820,631 - McGuigan , et al. October 26, 2
2010-10-26
Anti-Viral Pyrimidine Nucleoside Derivatives
App 20100222295 - McGuigan; Christopher ;   et al.
2010-09-02
Antiviral phosphoramidates
Grant 7,608,599 - Klumpp , et al. October 27, 2
2009-10-27
Phosphoramidate derivatives of nucleoside compounds for use in the treatment of cancer
App 20090215715 - McGuigan; Christopher ;   et al.
2009-08-27
Compounds useful as A.sub.3 adenosine receptor agonists
Grant 7,414,036 - Sevillano , et al. August 19, 2
2008-08-19
Phosphoramidate Derivatives
App 20070275910 - McGuigan; Christopher ;   et al.
2007-11-29
Heterocyclic compounds for use in the treatment of viral infections
App 20070191373 - McGuigan; Christopher ;   et al.
2007-08-16
Antiviral phosphoramidates
App 20070042988 - Klumpp; Klaus ;   et al.
2007-02-22
Phosphoramidate, and mono-, di-, and tri-phosphate esters of (1R, cis)-4-(6-amino-9H-purin-9-yl)-2-cyclopentene-1-methanol as antiviral agents
Grant 7,115,590 - Daluge , et al. October 3, 2
2006-10-03
Chemical compounds
App 20060142238 - McGuigan; Christopher
2006-06-29
Chemical compounds
Grant 7,018,989 - McGuigan , et al. March 28, 2
2006-03-28
Anti-viral pyrimidine nucleoside analogues
Grant 7,019,135 - McGuigan , et al. March 28, 2
2006-03-28
Compounds useful as A3 adenosine receptor agonists
App 20050101551 - Sevillano, Luis Garcia ;   et al.
2005-05-12
Antiviral purine derivatives
Grant 6,638,919 - McGuigan , et al. October 28, 2
2003-10-28
Anti-viral pyrimidine nucleoside analogues
App 20030176370 - McGuigan, Christopher ;   et al.
2003-09-18
Anti-viral pyrimidine nucleoside analogues
App 20030148967 - McGuigan, Christopher ;   et al.
2003-08-07
Chemical compounds
App 20030120071 - McGuigan, Christopher ;   et al.
2003-06-26
Anti-viral pyrimidine nucleoside analogues
Grant 6,573,247 - McGuigan , et al. June 3, 2
2003-06-03
Chemical compounds
Grant 6,455,513 - McGuigan , et al. September 24, 2
2002-09-24
Antiviral purine derivatives
App 20010031745 - McGuigan, Christopher ;   et al.
2001-10-18
Company Registrations
SEC0001412484McGuigan Christopher

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed